Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

NURE vs REZ: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

NURE Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 3–0 Matrix Metrics)

NURE Overall Winner 6-Pillar Tally: NURE 0 – 0 REZ (6 Tie) Matrix Metrics: NURE 3 – 0 REZ

As of Nov 16, 2026, Nuveen Short-Term REIT ETF (NURE) is the stronger overall head-to-head candidate over iShares Residential and Multisector Real Estate ETF (REZ) in the Tradestie Institutional Equity Comparison Engine, winning 3–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). NURE carries a Unified Composite Score of 39.5/100 (SELL) at $32.53 (N/M Forward P/E, N/A operating margin), whereas REZ carries 38.3/100 (SELL) at $94.27 (N/M Forward P/E, N/A operating margin).

  • Defensive Composite Rating Caution: Although NURE compares more favorably head-to-head, both NURE (39.5/100 SELL) and REZ (38.3/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About NURE vs REZ
NURE Cboe BZX Head-to-Head Winner
Nuveen Short-Term REIT ETF
Institutional Equity
$32.53
+0.42% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.26β · 18% Vol
Unified Composite Score
39.5 / 100 SELL
Tech 29.0 Fund 33.0 Flow 50.0 Mom 11.1
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 61
RSI-14: 60.7 · SMA20: $32.01 · SMA50: $30.80
REZ NYSE Arca
iShares Residential and Multisector Real Estate ETF
Institutional Equity
$94.27
+0.1% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.08β · 22% Vol
Unified Composite Score
38.3 / 100 SELL
Tech 39.0 Fund 39.0 Flow 50.0 Mom 31.7
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 58
RSI-14: 58.5 · SMA20: $92.72 · SMA50: $90.76

6-Pillar Scorecard Institutional Category Breakdown (NURE 0 – 0 REZ)

Columns: Metric · NURE · REZ
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale Tie
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap N/A N/A
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 25.0% (12th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: NURE (3) vs REZ (0)
Institutional Metric NURE REZ Criterion Row Edge
Market Capitalization
Scale
N/A N/A Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
86% ($27–$33) 67% ($82–$100) Stronger Trend NURE
Beta / 30D Volatility
Risk Regime
0.26β · 18% Vol 0.08β · 22% Vol Lower Realized Risk NURE
Unified Institutional Score
Composite Signal
39.5 / 100 (SELL) 38.3 / 100 (SELL) Higher Composite NURE
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon NURE +1.41 pp
NURE: +6.38% · REZ: +4.97%
3M Horizon NURE +2.7 pp
NURE: +2.56% · REZ: -0.14%
6M Horizon NURE +4.41 pp
NURE: +8.66% · REZ: +4.25%
1Y Horizon NURE +4.09 pp
NURE: +16.73% · REZ: +12.64%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NURE vs REZ. Trailing 12-month operating profitability (NURE N/A vs REZ N/A) and valuation multiples (NURE N/M vs REZ N/M Forward P/E) are benchmarked directly in Pillar 4 below.

NURE ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
REZ ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
NURE UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact NURE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
REZ UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 25.0%
IV Percentile 12th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact REZ Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
NURE Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
REZ Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ NURE vs REZ Key Questions & Quantitative Answers

As of Nov 16, 2026, Nuveen Short-Term REIT ETF (NURE) is the stronger overall head-to-head candidate over iShares Residential and Multisector Real Estate ETF (REZ) in the Tradestie Institutional Equity Comparison Engine, winning 3–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). NURE carries a Unified Composite Score of 39.5/100 (SELL) at $32.53 (N/M Forward P/E, N/A operating margin), whereas REZ carries 38.3/100 (SELL) at $94.27 (N/M Forward P/E, N/A operating margin). Defensive Composite Rating Caution: Although NURE compares more favorably head-to-head, both NURE (39.5/100 SELL) and REZ (38.3/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.

NURE and REZ split Growth & Scale metrics: NURE posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with REZ at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, NURE generates N/A in USD-normalized revenue versus N/A for REZ. In operating R&D and SG&A reinvestment, NURE deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for REZ.

NURE and REZ trade at balanced relative valuation multiples. NURE trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas REZ trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against NURE (N/A ROE) versus REZ (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, NURE carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.26β · 18% Vol realized risk). By comparison, REZ carries 25.0% implied volatility (12th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.08β · 22% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.